Mutational analysis of tumor suppressor gene p53 in feline vaccine site-associated sarcomas

American Journal of Veterinary Research

Volumn 61, Issue 10, 2000, Pages 1277-1281

  Nambiar, Prashant R ^a,b   Haines, Deborah M ^a   Ellis, John A ^a   Kidney, Beverly A ^a   Jackson, Marion L ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FELIDAE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CODON; GENETICS; INTRON; NUCLEOTIDE SEQUENCE; SARCOMA; TUMOR SUPPRESSOR GENE; VACCINATION;

ANIMALS; CAT DISEASES; CATS; CODON; DNA MUTATIONAL ANALYSIS; GENES, P53; INTRONS; SARCOMA; VACCINATION;

EID: 0034304298     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.1277     Document Type: Article

References (31)

1. Hendrick MJ, Brooks JJ. Postvaccinal sarcomas in the cat: histology and immunohistochemistry. Vet Pathol 1994;31:126-129.
2. Kass PH, Barnes WG Jr, Spangler WL, et al. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet Med Assoc 1993;203:396-405.
3. Cho Y, Gorina S, Jeffrey PD, et al. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 1994;265:346-355.
4. Kaufman WK, Paules RS. DNA damage and cell cycle checkpoints. FASEB J 1996;10:238-247.
5. Lee JM, Abrahamson JLA, Bernstein A. DNA damage, oncogenesis and p53 tumor suppressor gene. Mutat Res 1994;307: 573-581.
6. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351:453-456.
7. Kleihues P, Schauble B, zur Hausen A, et al. Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 1997;150:1-13.
8. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878.
9. Harris CC. The 1995 Walter Hubert Lecture - molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumor suppressor gene. Br J Cancer 1996;73: 261-269.
10. Soussi T, Caron de Fromentel C, Mechali M, et al. Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53. Oncogene 1987;1:71-78.
11. Soussi T, Caron de Fromentel C, May P. Structural aspects of the p53 protein in relation to gene evolution. Oncogene 1990;5:945-952.
12. Okuda M, Umeda A, Matsumoto Y, et al. Molecular cloning and chromosomal mapping of feline p53 tumor suppressor gene. J Vet Med Sci 1993;55:801-805.
13. Okuda M, Umeda A. Sakai T, et al. Cloning of feline p53 tumor-suppressor gene and its aberration in hematopoietic tumors. Int J Cancer 1994;58:602-607.
14. Mayr B, Heczko U, Schellander K, et al. Sequence of an exon of the feline p53 gene - mutation in a lymphosarcoma. Br Vet J 1993;149:387-390.
15. Mayr B, Schellander K, Schleger W, et al. Sequence of an exon of the canine p53 gene - mutation in a papilloma. Br Vet J 1994;150:81-84.
16. Mayr B, Schaffner G, Kurzbauer R, et al. Mutations in tumour suppressor gene p53 in two feline fibrosarcomas. Br Vet J 1995;151:707-713.
17. Mayr B, Schaffner G, Kurzbauer R, et al. Sequence of an exon of tumour suppressor p53 gene - a comparative study in domestic animals: mutation in a feline solid mammary carcinoma. Br Vet J 1995;151:325-329.
18. Mayr B, Reifinger M, Loupal G. Polymorphisms in feline tumour suppressor gene p53. Mutations in an osteosarcoma and a mammary carcinoma. Vet J 1998;155:103-106.
19. Baas IO, Mulder JW, Offerhaus GJ, et al. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172: 5-12.
20. Gannon JV, Greaves R, Iggo R, et al. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J 1990;9: 1595-1602.
21. Harris CC, Hollstein M. Clinical implications of the p53 tumor suppressor gene. N Engl J Med 1993;329:1318-1327.
22. Iggo R, Gatter K, Bartek J, et al. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335:675-679.
23. Martin SW, Meek AH, Willeberg P. Veterinary epidemiology. Principles and methods. Ames, Iowa: Iowa State University Press, 1987:74-75.
24. Kawai A, Noguchi M, Beppu Y, et al. Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor. Cancer 1994;73:2499-2504.
25. Vogelstein B, Kinzler KW. Tumor-suppressor genes. X-rays strike p53 again. Nature 1994;370:174-175.
26. Harris CC. P53: at the crossroads of molecular carcinogenesis and risk assessment. Science 1993;262:1980-1981.
27. Rideout WM III, Coetzce GA, Olumi AF, et al. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990;249:1288-1290.
28. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992;70:523-526.
29. Weinberg RA. Tumor suppressor genes. Science 1991;254: 1138-1146.
30. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-1238.
31. Srivastava S, Tong YA, Devadas K, et al. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome. Oncogene 1992;7:987-991.